SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0000950135-05-001784
Filing Date
2005-03-31
Accepted
2005-03-31 16:53:31
Documents
10
Period of Report
2004-12-31

Document Format Files

Seq Description Document Type Size
1 ANTIGENICS, INC. b53270aie10vk.htm 10-K 945251
2 EX-10.4 CURRENT SCHEDULE IDENTIFYING THE DIRECTORS AND EXECUTIVE OFFICERS b53270aiexv10w4.txt EX-10.4 635
3 EX-10.8 RESEARCH AGREEMENT DATED FEBRUARY 18, 1998 b53270aiexv10w8.txt EX-10.8 29204
4 EX-10.26 AMENDMENT NO.1 OF RESEARCH AGREEMENT b53270aiexv10w26.txt EX-10.26 3315
5 EX-10.28 LETTER AGREEMENT DATED FEBRUARY 10, 2005 b53270aiexv10w28.txt EX-10.28 1592
6 EX-21 SUBSIDIARIES OF ANTIGENICS b53270aiexv21.txt EX-21 441
7 EX-23 CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM b53270aiexv23.txt EX-23 1191
8 EX-31.1 CERTIFICATION OF CEO b53270aiexv31w1.txt EX-31.1 4723
9 EX-31.2 CERTIFICATION OF CFO b53270aiexv31w2.txt EX-31.2 4712
10 EX-32.1 CERTIFICATION OF CEO AND CFO b53270aiexv32w1.txt EX-32.1 2004
  Complete submission text file 0000950135-05-001784.txt   995973
Mailing Address 630 FIFTH AVENUE SUITE 2170 NEW YORK NY 10111
Business Address 630 FIFTH AVENUE SUITE 2170 NEW YORK NY 10111 2123324774
ANTIGENICS INC /DE/ (Filer) CIK: 0001098972 (see all company filings)

IRS No.: 061562417 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 000-29089 | Film No.: 05721260
SIC: 2836 Biological Products, (No Diagnostic Substances)